newsfilter
← Latest News
GlobeNewswire·

Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment Areas

CINCINNATI, Ohio, June 14, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (NASDAQ:BWV), a biotechnology company spanning multiple sectors, today announced the signing of an Asset Purchase Agreement (the "Agreement")